Viking Therapeutics, Inc VKTX
$34.36
-4.50%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $99.57
- Implied Upside
- +189.8%
- Price Target Range
- $65.00 – $125.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | JP MorganHardik Parikh |
Maintains | Overweight | $75 → $65 |
| 2026-07-30 | Canaccord GenuityEdward Nash |
Maintains | Buy | $107 → $114 |
| 2026-05-28 | Lake StreetDaniel Brims |
Initiates coverage on | Buy | $89 |
| 2026-05-01 | BTIGJeet Mukherjee |
Reiterates | Buy | $125 |
| 2026-04-30 | Cantor FitzgeraldSteve Seedhouse |
Maintains | Overweight | $105 → $100 |
| 2026-03-23 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-11-12 | Canaccord GenuityEdward Nash |
Maintains | Buy | $106 → $107 |
| 2025-10-29 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $106 |
| 2025-10-24 | JP MorganHardik Parikh |
Maintains | Overweight | $80 → $75 |
| 2025-10-23 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $98 → $102 |
| 2025-09-29 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-09-22 | BTIGJustin Zelin |
Reiterates | Buy | $125 |
| 2025-08-19 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-07-24 | Raymond JamesRyan Deschner |
Maintains | Strong buy | $125 → $122 |
| 2025-07-24 | CitigroupDavid Lebowitz |
Maintains | Neutral | $31 → $38 |
| 2025-06-25 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-04-28 | Cantor FitzgeraldSteven Seedhouse |
Initiates coverage on | Overweight | $104 |
| 2025-04-28 | Truist SecuritiesJoon Lee |
Reiterates | Buy | $95 → $75 |
| 2025-04-24 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $105 → $102 |
| 2025-04-24 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-04-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-04-08 | Goldman Sachs Richard Law |
Initiates coverage on | Neutral | $30 |
| 2025-03-26 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-03-11 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $102 |
| 2025-02-13 | ScotiabankGeorge Farmer |
Initiates coverage on | Sector outperform | $102 |
| 2025-02-07 | CitigroupDavid Lebowitz |
Initiates coverage on | Neutral | $38 |
| 2025-02-07 | Maxim GroupNaz Rahman |
Maintains | Buy | $120 → $70 |
| 2025-02-07 | B. Riley SecuritiesMayank Mamtani |
Reiterates | Buy | $109 → $96 |
| 2025-02-06 | Raymond JamesSteven Seedhouse |
Maintains | Strong buy | $122 → $125 |
| 2025-02-06 | Piper SandlerBiren Amin |
Maintains | Overweight | $74 → $71 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $34.36
- Market Cap
- $4.20 billion
- 52-Week Range
- $22.96 – $43.15
- Average Volume
- 1.89 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.